This is a preprint.
High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in Long-Term Care Facilities
- PMID: 33880479
- PMCID: PMC8057247
- DOI: 10.1101/2021.04.08.21255108
High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in Long-Term Care Facilities
Update in
- This article has been published with doi: 10.1038/s43856-021-00015-1
Abstract
Residents of Long-Term Care Facilities (LTCFs) represent a major share of COVID-19 deaths worldwide. Measuring the vaccine effectiveness among the most vulnerable in these settings is essential to monitor and improve mitigation strategies. We evaluated the early effect of the administration of BNT162b2 mRNA vaccines to individuals older than 64 years residing in LTCFs in Catalonia, a region of Spain. We monitored all the SARS-CoV-2 documented infections and deaths among LTCFs residents from February 6th to March 28th, 2021, the subsequent time period after which 70% of them were fully vaccinated. We developed a modeling framework based on the relation between community and LTFCs transmission during the pre-vaccination period (July -December 2020) and compared the true observations with the counterfactual model predictions. As a measure of vaccine effectiveness, we computed the total reduction in SARS-CoV-2 documented infections and deaths among residents of LTCFs over time, as well as the reduction on the detected transmission for all the LTCFs. We estimated that once more than 70% of the LTCFs population were fully vaccinated, 74% (58%-81%, 90% CI) of COVID-19 deaths and 75% (36%-86%, 90% CI) of all expected documented infections among LTCFs residents were prevented. Further, detectable transmission among LTCFs residents was reduced up to 90% (76-93%, 90%CI) relative to that expected given transmission in the community. Our findings provide evidence that high-coverage vaccination is the most effective intervention to prevent SARS-CoV-2 transmission and death among LTCFs residents. Conditional on key factors such as vaccine roll out, escape and coverage --across age groups--, widespread vaccination could be a feasible avenue to control the COVID-19 pandemic.
Keywords: COVID-19; long-term-care facilities; time series analysis; vaccination; vaccine effectiveness.
Conflict of interest statement
Competing interests: All authors declare no competing interests.
Figures
Similar articles
-
High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in long-term care facilities.Commun Med (Lond). 2021 Jul 16;1:16. doi: 10.1038/s43856-021-00015-1. eCollection 2021. Commun Med (Lond). 2021. PMID: 35602197 Free PMC article.
-
High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in Long-Term Care Facilities.Res Sq [Preprint]. 2021 Apr 12:rs.3.rs-355257. doi: 10.21203/rs.3.rs-355257/v1. Res Sq. 2021. Update in: Commun Med (Lond). 2021 Jul 16;1:16. doi: 10.1038/s43856-021-00015-1. PMID: 33880465 Free PMC article. Updated. Preprint.
-
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.Lancet Infect Dis. 2021 Nov;21(11):1529-1538. doi: 10.1016/S1473-3099(21)00289-9. Epub 2021 Jun 23. Lancet Infect Dis. 2021. PMID: 34174193 Free PMC article.
-
First-Dose Coronavirus 2019 Vaccination Coverage among the Residents of Long-Term Care Facilities in France.Gerontology. 2022;68(5):546-550. doi: 10.1159/000517793. Epub 2021 Aug 11. Gerontology. 2022. PMID: 34380133 Free PMC article.
-
Factors influencing long-term care facility performance during the COVID-19 pandemic: a scoping review.BMC Health Serv Res. 2024 Aug 7;24(1):901. doi: 10.1186/s12913-024-11331-2. BMC Health Serv Res. 2024. PMID: 39113065 Free PMC article. Review.
References
-
- Lipsitch M, Dean NE. Understanding COVID-19 vaccine efficacy. Science. 2020;370: 763–765. - PubMed
-
- Moustsen-Helms IR, Emborg H-D, Nielsen J, Nielsen KF, Krause TG, Mølbak K, et al. Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA Covid-19 Vaccine in long-term care facility residents and healthcare workers – a Danish cohort study. doi:10.1101/2021.03.08.21252200 - DOI
-
- Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, et al. Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study). SSRN Electronic Journal. doi:10.2139/ssrn.3790399 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous